Clinical Trial Detail

NCT ID NCT02078752
Title A Study Of PF-06647263 In Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

PF-06647263

Age Groups: adult

No variant requirements are available.